SCHEMBL21834072

SCHEMBL21834072

O=S(=O)(c1ccc(F)cc1)N1CC2=C(CNC2)C1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PKM P14618 6/20 0.53
MMP2 P08253 1/20 0.50
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
MAPT P10636 1/20 0.47
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 1/20 0.46
MCOLN3 Q8TDD5 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
POLB P06746 2/20 0.44
GPR183 P32249 1/20 0.43
PKLR P30613 1/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21911219 0.83 PKM (0.56) PKMMMP2MEN1KMT2AALDH1A1
SCHEMBL21004687 0.79 LMNA (0.46) PKMMEN1KMT2AMAPTALDH1A1
Hydrochloric Acid SCHEMBL20511341 0.77 LMNA (0.46) PKMMEN1KMT2AMAPTALDH1A1
SCHEMBL21834214 0.76 PKM (0.53) PKMMMP2MEN1KMT2AMAPT
SCHEMBL21005028 0.75 PSEN1 (0.46) POLBKDM4E
SCHEMBL1711115 0.75 PKM (0.85) PKMMEN1KMT2AMAPTALDH1A1
SCHEMBL1797016 0.75 MAPT (0.69) PKMMEN1KMT2AMAPTALDH1A1
Hydrochloric Acid SCHEMBL20511356 0.74 PSEN1 (0.46) POLBKDM4E
Hydrochloric Acid SCHEMBL30437494 0.74 PSEN1 (0.46) POLBKDM4E
Hydrochloric Acid SCHEMBL1180894 0.74 MAPT (0.67) PKMMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113226356-B Activation of pyruvate kinase R 诺沃挪第克健康护理股份公司 2025-03-04 CN disclosed
US-20230055923-A1 ACTIVATING PYRUVATE KINASE R NOVO NORDISK HEALTH CARE AG (CH) 2023-02-23 US disclosed
CN-113226356-A Activating pyruvate kinase R 福马治疗股份有限公司 2021-08-06 CN disclosed
EP-3852791-A1 ACTIVATING PYRUVATE KINASE R Forma Therapeutics, Inc. (US) 2021-07-28 EP disclosed
WO-2020061255-A1 ACTIVATING PYRUVATE KINASE R FORMA THERAPEUTICS, INC. (US) 2020-03-26 WO disclosed
WO-2020061255-A1 ACTIVATING PYRUVATE KINASE R FORMA THERAPEUTICS, INC. (US) 2020-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055923-A1 ACTIVATING PYRUVATE KINASE R PDK1, PDK2, PKLR PKM 9/4885MMP2 4299/4885MEN1 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.